spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  MDR-TB 

 HSMN NewsFeed - 4 Oct 2019
Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 22 Mar 2019
Bruker Announces Improved Assay for Tuberculosis Diagnostics in Novel Liquid Array(TM) Format for Improved Multiplexing
Diagnostics Product Launch
 HSMN NewsFeed - 21 Aug 2018
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
Diagnostics
 HSMN NewsFeed - 13 Jun 2018
Akonni Biosystems Announces the Appointment of Lawrence Firestone as Executive Vice President and Chief Financial Officer
Diagnostics Personnel
 HSMN NewsFeed - 24 Aug 2017
Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba(TM)) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Diagnostics Personnel
 HSMN NewsFeed - 26 Aug 2014
Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2014
Otsuka Wins European Marketing Authorization for Deltyba(TM) (delamanid)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Jan 2014
Janssen Announces New Group Targeting Unmet Global Health Needs
Biopharmaceuticals
 HSMN NewsFeed - 17 Jul 2013
Sequella Acquires Exclusive Worldwide Rights to Pfizer’s Sutezolid, Currently in Clinical Development for Tuberculosis
Biopharmaceuticals Licensing
 HSMN NewsFeed - 31 Dec 2012
FDA Grants Accelerated Approval for SIRTURO(TM) (bedaquiline) as Part of Combination Therapy to Treat Adults with Pulmonary Multi-Drug Resistant Tuberculosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Oct 2011
Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership
Biopharmaceuticals
 HSMN NewsFeed - 22 Mar 2007
Lilly Announces Additional $50 Million Investment in Global Tuberculosis Partnership
Biopharmaceuticals
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.